Skip to main content

and
  1. No Access

    Article

    CDC20 and PTTG1 are Important Biomarkers and Potential Therapeutic Targets for Metastatic Prostate Cancer

    Metastatic prostate cancer (mPCa) is responsible for most prostate cancer (PCa) deaths worldwide. The present study aims to explore the molecular differences between mPCa and PCa.

    Liang Dai, Zi-Xuan Song, Da-Peng Wei, Ji-Dong Zhang, Jun-Qiang Liang in Advances in Therapy (2021)